Agoracom Blog Home

Posts Tagged ‘Symp2pass’

Predictmedix $PMED.ca $PMEDF Announces Technology Deployments at Major Office Towers in Calgary and Edmonton in Partnership With Aspen Properties $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM at 9:51 AM on Monday, April 19th, 2021
PMED PredictMedix

TORONTO, April 19, 2021 (GLOBE NEWSWIRE) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce deployment of Safe Entry Stations at 4 key office towers in downtown Calgary and Edmonton in partnership with Apsen Properties and Juiceworks Exhibits (Juiceworks).

Calgary’s The Edison, Palliser Complex, The Ampersand and Edmonton’s Bell Tower are raising the bar by providing a completely voluntary infectious disease symptom screening option for their tenants. This is a multi-unit, 24 month contract.

Safe Entry Stations are powered by artificial intelligence (AI).  Military-grade multispectral cameras use thermal imaging and a proprietary hardware configuration to capture data patterns that are analyzed instantly.

They provide an immediate assessment of individuals looking to access shared spaces by screening for multiple symptoms associated with infectious diseases, such as COVID-19. Moreover, the technology is 100% non-invasive, expediting the screening process even at high volume locations.

This ground-breaking technology is poised to change the way we look at the screening and diagnosis of infectious diseases. Our autonomous, comprehensive AI algorithms are continuously evolving via machine learning, are deployed instantly on the cloud, and deliver a multi-symptom analysis within seconds.

Read More: https://agoracom.com/ir/Predictmedix/forums/discussion/topics/759282-predictmedix-announces-technology-deployments-at-major-office-towers-in-calgary-and-edmonton-in-partnership-with-aspen-properties/messages/2312537#message

Predictmedix $PMED.ca $PMEDF Announces a 2-Year Revenue Contract With Flow Alkaline Spring Water for North American Operations $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM at 10:49 AM on Wednesday, April 14th, 2021
PMED PredictMedix

TORONTO, April 14, 2021 (GLOBE NEWSWIRE) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce a 24 month, multi-unit contract to deploy Safe Entry Stations throughout the North American operations of Flow Water Inc. (“Flow Alkaline Spring Water” or “Flow”). The partnership marks the successful completion of our initial pilot, as the technology is now scaled and deployed across all of Flow’s operations both in Canada and the USA.

A pioneer in the health and wellness arena, Flow was one of the first in Eastern Canada to partner with Predictmedix and Juiceworks Exhibits (JUICEWORKS) to implement Safe Entry Stations at their Aurora facilities in August 2020. North America’s first socially responsible artisan alkaline water plant, Flow continues its spirit of innovation by incorporating AI-powered solutions to improve operational efficiencies.

Initially deployed as a beta site, Safe Entry quickly became an integral part of Flow’s health and safety protocol. The autonomous nature of the technology and the robust multi-symptom screening imparted an added sense of security among their workforce.

As part of their ongoing commitment to their valued staff, they have entered into a multi-unit revenue contract for two years and will now be expanding the program to their remaining facilities in Aurora, Ontario and Verona, Virginia.

“Implementing Safe Entry at our plants has dramatically decreased our absenteeism and increased employee peace of mind. Keeping our staff safe is top priority, and as such, we were determined to implement the best available solution, which we found in Safe Entry,” affirms Nicholas Reichenbach, Founder & Executive Chairman of Flow.

Read More: https://agoracom.com/ir/Predictmedix/forums/discussion/topics/759031-predictmedix-announces-a-2-year-revenue-contract-with-flow-alkaline-spring-water-for-north-american-operations/messages/2311881#message

Predictmedix $PMED.ca $PMEDF and JUICEWORKS Form Strategic Partnership with CONNECTUS Global to Deploy Safe Entry Stations Nationwide $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM at 9:09 AM on Monday, April 5th, 2021
PMED PredictMedix

TORONTO, April 05, 2021 (GLOBE NEWSWIRE) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce a partnership to deploy Safe Entry Stations in partnership with North American industry leaders JUICEWORKS EXHIBITS (JUICEWORKS) and CONNECTUS Global.

SAFE ENTRY STATIONS leverage military-grade multispectral cameras paired with Predictmedix’s proprietary, clinically based artificial intelligence algorithms. They provide an immediate assessment of individuals looking to access shared spaces by checking for multiple symptoms associated with infectious diseases such as COVID-19.

This ground-breaking technology is poised to change the way we look at screening and, eventually, the diagnosis of infectious diseases. Autonomous, comprehensive analysis provides peace of mind to individuals entering shared spaces, be it for work, entertainment, or necessity.

Mike Anderson, CEO of CONNECTUS Global, commented:

“Seeing this level of innovation is exciting to drive adoption of digital processes throughout the public and private sectors, what PREDICTMEDIX and JUICEWORKS are doing is revolutionary to introduce a new level of health measurement into the community.”

Read More: https://agoracom.com/ir/Predictmedix/forums/discussion/topics/758511-predictmedix-and-juiceworks-form-strategic-partnership-with-connectus-global-to-deploy-safe-entry-stations-nationwide/messages/2310850#message

Predictmedix Inc. $PMED.ca $PMEDF Announces LOI to Acquire Symp2pass Inc.

Posted by AGORACOM at 1:44 PM on Tuesday, March 23rd, 2021
PMED PredictMedix

TORONTO, March 23, 2021 (GLOBE NEWSWIRE) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce it has entered into a letter of intent (the “LOI”), to acquire Symp2Pass Inc. (“Symp2pass”) (the “Acquisition”). The LOI was executed on February 24, 2021 and currently Predictmedix and Symp2pass are working on the definitive agreement.

Symp2Pass is a profitable, revenue generating AI powered IoT product suite of technologies developed by SmartCone Technologies Inc. Symp2Pass had revenues of $2.27 million for the fiscal year ending December 31, 2020 (unaudited) with earnings before taxes of approximately $205,000.

Symp2Pass is one of the first end-to-end advanced touchless health and wellness testing solutions that currently provides advanced COVID-19 symptom screening from multiple independent sensors with geolocation mapping making it unique and more reliable than a single test or measurement. Much like Predictmedix’s Safe Entry Station units, Symp2Pass affords hardware product installation that is coupled with scalable, AI powered software technologies. Beyond the standard questionnaire based screening tools, Symp2Pass measures actual temperature, capable of cough identification, and scent recognition, all critical parts of a more effective screening.

Symp2Pass also affords integration capabilities with other IoT products such as RFID bracelets and QR Codes and associated scanners that can assist workplaces in comprehensive employee tracking, tracing, and reporting tying those initial measurements for individuals with multiple automated measurements in various situations during the day. The data collected from the hardware components are immediately uploaded on the cloud and is synthesized with AI-powered technologies within seconds to deliver instant results.

The strategic acquisition will catalyze growth prospects for Predictmedix and will allow the company to offer world class products in line with our mission of becoming the first line of defense in improving workplace health and safety.

Read More: https://agoracom.com/ir/Predictmedix/forums/discussion/topics/757894-predictmedix-inc-announces-loi-to-acquire-symp2pass-inc/messages/2309439#message